The Difference in Health Outcomes After Drinking Cow's Milk Compared to Oat Milk - a Pilot Randomized Controlled Study

NCT ID: NCT06764173

Last Updated: 2025-01-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-08-20

Study Completion Date

2024-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A new dietary trend is switching from cow\'s milk to plant-based milk alternatives, driven by the belief that this switch is beneficial for health reasons in addition to the sustainability aspect of a plant-based diet. The trend of using plant-based milk alternatives is especially popular among young women, of whom iodine nutrition also is of concern, both globally and in Norway. Some of the plant-based alternatives are fortified with iodine, but both the bio-availability and whether is feasible to consume large enough amounts of the milk to provide an adequate iodine intake is unknown. Another aspect is that the effect of cow's milk intake on blood lipids has been widely studied, however, there is a lack of studies on the effect of oat milk consumption on blood lipids.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this study is two-fold

1. To compare the iodine nutrition in those drinking cow's milk compared to oat milk
2. To compare the levels of blood lipids in those drinking cow's milk compared to oat milk

Recruitment Women aged 18-40 years deemed eligible according to the inclusion and exclusion criteria will be asked to participate in the study. The recruitment will occur at the University of Bergen during the fall of 2024. Those willing to participate will contact the study personal by a digital form. Before participation, signed informed consent must be provided.

Participants who uses dietary supplements will be asked to cease these during the intervention. The exception is those with clinical deficiency e.g. anemia.

Sample size This is a pilot study testing both the feasibility of the interventions and if we observe any changes in the outcomes. To our knowledge, no trials have been conducted comparing cow's milk and oat milk before. Hypothesizing that oat milk will decrease total cholesterol due to its content of beta-glucans and a higher content of PUFAS compared to cow's milk. For the cow's milk group, we expect the total cholesterol in the cow's milk group to stay the same before and after intervention. A mean difference of 0.6 mmol/l between the groups, will need groups of 174 with an alpha of 0.05 and power of 80%. Due to the limitations and time frame of a master thesis, we propose 15 persons per arm, thus including 30-40 participants. In our experience with similar intervention studies in the same group of participants, this sample size is feasible within the timeframe of a master\'s thesis.

Study design A pilot randomized study design will be performed, where the participants will be randomly divided into groups to either drink cow's milk or oat milk for 4 weeks in a dose of 6 dl per day, which corresponds to the dietary recommendation of "three portions of dairy products a day". The cow milk and oat milk will be provided to the participants and handed out in regular time intervals from the study center. The participants should not make any other changes to their habitual diet. Blood and urine samples will be collected at the Research Unit for Health Surveys. Additionally, the performance of a wearable patch for hydration monitoring (https://www.modesensors.com/) will be assessed in a subsample of 8 participants.

Measurements Anthropometric measurements Body weight and height will be measured at baseline, and body weight again at the end visit.

Dietary assessment 24-hour recalls will be performed several times during the intervention period to assess compliance with the intervention, monitor any deviations from habitual dietary intake, and to be able to calculate iodine intake from the diet.

Iodine nutrition 24-hour urine will be collected at baseline and after two weeks of intervention. In addition, two spot urine samples will be collected at baseline. The urine samples will be analyzed for iodine concentration (UIC) with ICP-MS at the Institute of Marine Research. In addition, creatinine and osmolarity will be measured both in the spot and 24-hour urine samples. Both thyroglobulin, TSH, fT3, and fT4 will be measured in serum at baseline and end visit. Iodine intake from the diet will be calculated based on the repeated 24-hour recalls. The participants are asked to keep a record of every bathroom visit and if there are any deviations (e.g. spillage).

Blood lipids Both triacylglycerol, total cholesterol, LDL, and HDL cholesterol will be measured at baseline and the end visit. All blood samples will be analyzed at the MBF at Haukeland University Hospital.

Compliance To assess compliance with the intervention milk, the participant is asked to fill in a compliance journal of their daily intake.

Ethics and safety Participants are provided with information about the study both orally and in writing and must sign a consent form to be included in the study before the baseline visit. The principle of the Declaration of Helsinki will be applied. The participants can withdraw from the study at any time without explanation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Plant-based Milk Iodine Nutrition Status Lipids

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cow's milk

6 dl of cow's milk daily

Group Type ACTIVE_COMPARATOR

Oat drink

Intervention Type OTHER

6 dl of oat drink daily

Cow's milk

Intervention Type OTHER

6 dl of cow's milk daily

Oat drink

6 dl of Oat drink daily

Group Type EXPERIMENTAL

Oat drink

Intervention Type OTHER

6 dl of oat drink daily

Cow's milk

Intervention Type OTHER

6 dl of cow's milk daily

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Oat drink

6 dl of oat drink daily

Intervention Type OTHER

Cow's milk

6 dl of cow's milk daily

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* women aged 18-40 years
* healthy
* habitual milk drinkers

Exclusion Criteria

* pregnant or lactating
* known thyroid disease
* planning to conceive
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institute of Marine Research

OTHER

Sponsor Role collaborator

University of Bergen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hanne Rosendahl-Riise, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Bergen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Unit for Health Surveys

Bergen, , Norway

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Norway

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

712892

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pre/Term Milk Profiling
NCT02052245 COMPLETED